NCT01562327View on ClinicalTrials.gov

A Non-interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Tocilizumab

Participants received tocilizumab according to individualized physician-prescribed regimens.

Trial Locations (7)

1888

San Juan Bautista

1900

La Plata

5400

San Juan

C1426AAL

Buenos Aires

C1428DQG

Buenos Aires

C1221ADC

Ciudad Autonoma de

T4000IFP

San Miguel de Tucumán

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01562327 - A Non-interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter